文献速递皮肤肿瘤

非裔美国及黑人蕈样肉芽肿/Sézary综合征患者的结局与预后因素:157例转诊癌症中心回顾性分析

Outcomes and prognostic factors in African American and black patients with mycosis fungoides/Sézary syndrome: Retrospective analysis of 157 patients from a referral cancer center.
PubMed 文献 · J Am Acad Dermatol · 2019-09-06

该回顾性研究分析了1994-2018年间157例自认非裔美国人或黑人MF/SS患者的临床特征与随访数据,其中早期MF 122例、晚期35例,中位随访25个月。

要点

  • 色素减退是预后良好的标志,与更好的总生存和无进展生存相关。
  • 临床分期、TNMB分类、斑块性疾病和LDH升高与结局显著相关。
  • 人口学和社会经济因素在该队列中未显示预后作用。

核心结论

  • 非裔美国及黑人MF/SS患者的临床表现和结局具有异质性,临床特征有助于风险分层。

研究设计与样本

  • 单中心回顾性分析,纳入157例自认非裔美国人或黑人MF/SS患者,1994-2018年就诊,中位随访25个月。

主要发现

  • 122例为早期MF,35例为晚期疾病。
  • 因疾病死亡或进展的患者中超过80%有红斑或色素沉着而无色素减退。
  • 临床分期、TNMB分类、斑块性疾病和血清乳酸脱氢酶升高与结局显著相关。
  • 人口学和社会经济参数与预后无关。

临床怎么用

  • 临床特征如色素减退、分期、TNMB分类、斑块性疾病和LDH升高可用于风险分层,指导个体化治疗。

局限性

  • 单中心回顾性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prevalence of mycosis fungoides/Sézary syndrome (MF/SS) is higher in the black population than in the white population in the United States and worse outcomes have been observed in black patients. OBJECTIVE: To describe the outcomes and to identify prognostic factors in African American and black patients with MF/SS. METHODS: Clinical features and follow-up data were analyzed in 157 self-identified African American or black patients seen during 1994-2018. RESULTS: We included 122 patients with early stage MF and 35 patients with advanced-stage disease (median follow-up of 25 months). Overall, >80% of the patients who died from disease or progressed had erythema or hyperpigmentation without hypopigmentation. Patients with hypopigmentation, either as the sole manifestation or in combination with other lesions, had better overall survival (P = .002) and progression-free survival (P = .014). Clinical stage, TNMB classification, plaque disease, and elevated serum lactate dehydrogenase were also significantly associated with outcomes. Demographic and socioeconomic parameters were not associated with prognosis. LIMITATIONS: A retrospective study at a single cancer center. CONCLUSION: MF/SS manifestations and outcomes in African American and black patients are heterogeneous. Demographic and socioeconomic factors do not seem to have a prognostic role, while clinical characteristics might help in the stratification of risk of progression and shorter survival, allowing for individually tailored therapeutic interventions.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Geller S, Lebowitz E, Pulitzer MP, et al. Outcomes and prognostic factors in African American and black patients with mycosis fungoides/Sézary syndrome: Retrospective analysis of 157 patients from a referral cancer center. J Am Acad Dermatol. 2019. PMID: 31499157. doi:10.1016/j.jaad.2019.08.073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。